阅读说明：本技术 一种药物组合物及其在治疗鼻炎中的应用 (Pharmaceutical composition and application thereof in treating rhinitis ) 是由 高光兴 于 2020-06-08 设计创作，主要内容包括：本发明公开了一种药物组合物及其在治疗鼻炎中的应用,涉及治疗鼻炎技术领域,本发明通过维生素C和抗过敏药物两种药物组合服用,提高人体的免疫力和对异常变化的应变能力,使得鼻炎和过敏复发的症状越来越轻微,逐步达到治疗鼻炎的效果。(The invention discloses a pharmaceutical composition and application thereof in treating rhinitis, and relates to the technical field of treating rhinitis.)

1. A pharmaceutical composition for treating rhinitis is characterized by comprising a vitamin C tablet and an antiallergic drug.

2. The pharmaceutical composition for treating rhinitis according to claim 1, wherein the vitamin C tablets comprise various metered vitamin C tablets and medicines taking vitamin C as a main component.

3. The pharmaceutical composition for treating rhinitis according to claim 2, wherein the antiallergic agent is one of the first-generation antiallergic agents of finasteride and chlorpheniramine.

4. The pharmaceutical composition for treating rhinitis according to claim 2, wherein the antiallergic agent is one of the second-generation antiallergic agents, i.e. aspirin, loratadine, terfenadine, cetirizine and ketotifen.

5. The pharmaceutical composition for treating rhinitis according to claim 2, wherein said antiallergic agent is one of the third-generation antiallergic agents levocetirizine, desloratadine and fexofenadine.

6. The pharmaceutical composition for treating rhinitis according to claim 2, wherein said antiallergic agent is one of the subsequently developed antihistaminic antiallergic agents.

7. A pharmaceutical composition for the treatment of rhinitis according to claim 3, wherein said antiallergic is preferably chlorpheniramine maleate.

8. Use of a pharmaceutical composition according to any one of claims 1 to 7 for the treatment of rhinitis, wherein the vitamin C tablets are administered in a dose of 100 mg/tablet, two tablets for an adult and three times a day, the antiallergic agent is administered in a dose of 4 mg/tablet, one tablet for an adult and one to three times a day, the two agents are administered in combination, and after the allergic symptoms are alleviated, the administration of the antiallergic agent is discontinued and the vitamin C tablets are administered alone for 3 months.

Technical Field

The invention relates to the technical field of rhinitis treatment, in particular to a pharmaceutical composition and application thereof in rhinitis treatment.

Background

Rhinitis is acute or chronic inflammation of the nasal mucosa or submucosal tissue caused by viral infection, bacterial infection, and irritation of irritants, which results in damage to the nasal mucosa or submucosal tissue. Rhinitis causes excessive mucus production, often resulting in runny nose and nasal obstruction.

The existing treatment method is a traditional Chinese medicine method, but has long time, slow effect and high cost. Western medicine combines medicine and laser operation, sealing, acupuncture and micro-gram-level micro-hormone inhalation, has obvious effect in a short time, but mostly has relapse after a period of time, and is high in cost. The patients who have relapsed by the two common rhinitis treatment methods have low treatment wish, and basically do not seek treatment any more, but only suffer from the pain caused by the rhinitis and the inconvenience brought to life. Therefore, the invention provides a pharmaceutical composition capable of solving the problems and application thereof in treating rhinitis.

Disclosure of Invention

The invention aims to provide a pharmaceutical composition and application thereof in treating rhinitis, so as to solve the problems in the background technology.

In order to achieve the purpose, the invention provides the following technical scheme:

a pharmaceutical composition for treating rhinitis comprises vitamin C tablet and antiallergic medicine.

The vitamin C tablets comprise various metered vitamin C tablets and medicines taking the vitamin C as a main component.

The antiallergic drug is one of first-generation antiallergic drugs of finasteride and chlorphenamine.

The antiallergic drug is one of the second generation antiallergic drugs of the esmin, the loratadine, the terfenadine, the cetirizine and the ketotifen.

The antiallergic drug is one of levocetirizine, desloratadine and fexofenadine which are third-generation antiallergic drugs.

The antiallergic drug is one of the subsequently developed antihistaminic antiallergic drugs.

The antiallergic medicine is preferably chlorpheniramine maleate.

The application of a pharmaceutical composition in treating rhinitis comprises the vitamin C tablets in a dosage of 100 mg/tablet, wherein the vitamin C tablets are taken by adults two tablets at a time and three times a day, the antiallergic drugs are taken by adults one tablet at a time and one to three times a day in a dosage of 4 mg/tablet, the two drugs are taken in combination, after allergic symptoms are relieved, the antiallergic drugs are stopped to be taken, and the vitamin C tablets are taken alone for 3 months.

The cause of rhinitis is complex, mainly including viral infection, genetic factors, susceptibility of nasal mucosa, and antigen (inhalant allergen and inhalant allergen), which is an abnormal immune response of human body. The clinical manifestations of rhinitis are nasal obstruction, nasal discharge, hyposmia, headache, dizziness, anorexia, fatigue, hypomnesis, insomnia and sneezing. According to symptom analysis, the pathogenesis is an essential means for symptomatic treatment. The prior treatment schemes are basically directed to nose treatment, such as operation, laser treatment, cleaning and hormone treatment, and the traditional Chinese medicine is deeply applied to the lung. There are few restorative treatments for immunity. The invention mainly considers how to improve the immunity of the human body and improve the strain capacity of the organism, thereby reducing the probability of rhinitis attack and relieving the pain of patients. Vitamin C has strong function of improving human immunity, because leucocytes contain abundant vitamin C, the vitamin C of the leucocytes is reduced rapidly when the organism is infected, the vitamin C can enhance chemotaxis and deformability of the neutrophilic granulocytes, and the bactericidal capability is improved. Vitamin C can also promote the generation of lymphocytes and improve the recognition and killing of foreign and malignant cells by the body. Vitamin C is also involved in immunoglobulin synthesis. The ability of vitamin C can undoubtedly act on the deep etiology of rhinitis, thereby achieving the effect of treating rhinitis.

Because a human body is subjected to abnormal stimulation, such as severe pain, cold, hypoxia and mental stimulation, and a stress state for resisting the abnormal stimulation is triggered, the state is accompanied by a series of body including sympathetic nerve excitation, secretion of adrenal medulla and corticoids is increased, adrenaline and noradrenaline secreted by the adrenal medulla are converted from tyrosine, vitamin C is required to participate in the process, after the weather turns cold, a plurality of rhinitis patients continuously sneeze after getting up, flow nasal water and have nasal obstruction when the temperature difference is large, which are caused by low strain capacity of the human body to the cold, the invention improves the abnormal stimulation capacity of the strain cold of the body by taking the vitamin C, and is undoubtedly a remedy for relieving the symptoms of the rhinitis. In addition, one symptom of rhinitis is easy to fatigue, the fatigue further causes the immunity to be reduced, a few human animals cannot synthesize the vitamin C by themselves, and the rhinitis patients have the characteristic of vitamin C deficiency through food and medicine intake and analysis from the symptom, and the supplement of the vitamin C is greatly beneficial to improving the vitality of the human body and eliminating the fatigue of the patients.

The goal of treating rhinitis by improving the immunity of the human body is a relatively long process, typically 2-3 years. The symptoms of allergic rhinitis cannot be relieved for a short time. The allergen of allergic rhinitis is complex, and in order to effectively relieve the pain of a patient in a short time, an anti-allergic medicament needs to be taken together with the allergen, the first generation, the second generation and the third generation of chlorpheniramine can be selected, and the long-term administration of the anti-allergic medicament can generate medicament resistance and certain side effect, so that the time for taking the chlorpheniramine anti-allergic medicament does not exceed one week generally, and the allergic symptoms stop after being relieved.

The invention has the beneficial effects that: the invention relates to a pharmaceutical composition and application thereof in treating rhinitis, wherein the composition is taken by combining vitamin C and an antiallergic drug, so that the immunity and the strain capacity to abnormal changes of a human body are improved, and the symptoms of rhinitis and allergic recurrence are more and more slight, thereby gradually achieving the effect of treating various rhinitis.

Detailed Description

In order to make the technical means, the creation features, the achieved objects and the effects of the present invention easily understood, the present invention will be further described with reference to the following embodiments.

The medicine provided by the invention is not particularly limited in source and can be purchased in a drugstore, and the purity of the medicine provided by the invention is not limited and meets the national medicine standard.